DMD Awareness
Blog

Vaccinations in Duchenne Muscular Dystrophy

Vaccinations in DMD: influenza, pneumococcal, COVID-19, why respiratory protection matters more, and what to discuss with the care team.

By Helena Marsh 4 min read
Last reviewed

Vaccinations in Duchenne muscular dystrophy carry weight beyond routine pediatric care. A respiratory infection that would be a difficult week for a healthy child can be a hospital admission, prolonged recovery, or pneumonia for a patient with Duchenne muscular dystrophy and reduced respiratory reserve. Vaccines are the single most effective measure for preventing those infections, and they should be planned with the same care as any other part of the regimen.

This post is a practical overview. The actual schedule belongs to the care team, which often includes the neuromuscular specialist, pediatrician, and pulmonologist.

Why vaccinations matter more in DMD

DMD progressively weakens the muscles that move the chest and abdomen. As respiratory reserve declines, the same respiratory infection that produces only cough and congestion in a healthy person can produce hypoventilation, secretion retention, and pneumonia in someone with DMD.

The result is a higher cost-per-infection and a higher value-per-prevention. Patient organizations classify routine vaccinations as a core part of care, not as an optional add-on. (PPMD, Vaccination Recommendations)

For background on the respiratory trajectory, see respiratory care in DMD and sleep in DMD.

Influenza

Annual influenza vaccination is recommended for all patients with DMD, regardless of age or corticosteroid use, as soon as the seasonal vaccine becomes available. Influenza is one of the respiratory infections most likely to decompensate a patient with reduced reserve. (PPMD, Vaccination Recommendations)

An important practical point: the live-attenuated nasal-spray influenza vaccine is generally avoided in DMD because of immunosuppression risk in patients on long-term corticosteroids. The inactivated injected influenza vaccine is the preferred option.

Household contacts and caregivers should also be vaccinated. Cocooning the vulnerable patient by protecting the people around them reduces transmission risk inside the home.

Pneumococcal disease

Pneumococcal infections are a serious risk for patients with DMD, especially after the onset of significant respiratory muscle weakness. Both pneumococcal conjugate vaccines (PCV) and the 23-valent pneumococcal polysaccharide vaccine (PPSV23) are typically used, in sequences that depend on age and prior vaccinations. The specific schedule is set by the care team.

For respiratory illness management once an infection occurs, see emergency preparedness for DMD families.

COVID-19

COVID-19 vaccination is recommended for patients with DMD and their household contacts in line with up-to-date national guidance. Patients with DMD are at higher risk of respiratory and cardiac complications from SARS-CoV-2 infection than the general population, and the cost of decompensation is high. (PPMD, COVID-19 Vaccination and Approved Treatments)

Boosters and updated formulations follow national schedules. Discuss timing with the care team, especially around scheduled surgeries, infusions, or immunosuppressive regimens.

A patient-reported survey on SARS-CoV-2 morbidity and vaccination in DMD documented the clinical course and acceptance of vaccination in this population. (Morbidity and vaccination against SARS-CoV-2 in DMD, PMC)

Other routine vaccinations

Patients with DMD should also follow national schedules for routine pediatric and adult vaccinations, including:

  • DTaP / Tdap (diphtheria, tetanus, pertussis).
  • MMR (measles, mumps, rubella).
  • Varicella, with caution about live vaccines when significant immunosuppression is present.
  • HPV at the recommended ages.
  • Hepatitis A and B per national schedule.
  • Meningococcal vaccines per age and risk.

Live vaccines (MMR, varicella, nasal-spray influenza, yellow fever, BCG) require additional consideration when a patient is on high-dose corticosteroids or other immunosuppressants. The care team weighs timing against immunosuppressive status.

National neuromuscular guidance documents, including from Australia and the World Duchenne organization, give clinicians and families summaries to share with primary care. (AUSNMD, Immunisations) (World Duchenne, Why Vaccinations are Crucial for People with Duchenne and Becker)

Steroid stress dosing during illness

A practical point families should plan for: when a patient on long-term corticosteroids develops a febrile illness, additional steroid dosing may be needed to prevent adrenal crisis. This is part of standard DMD emergency planning and should be reviewed at each clinic visit.

For background, see corticosteroids in DMD and emergency preparedness for DMD families.

Who coordinates vaccinations

In most settings, the primary-care pediatrician or family doctor administers vaccines, while the neuromuscular team flags any DMD-specific timing or contraindications. The care team typically coordinates with the prescribing clinician for steroid-related considerations, infusion-related timing, and clinical trial protocols when relevant.

For background, see the DMD care team explained.

What families can ask

A short list at clinic visits:

  • Is the patient up to date on influenza, COVID-19, and pneumococcal vaccines?
  • Are household contacts vaccinated, particularly against influenza?
  • Are any planned vaccines live, and should timing be reconsidered given current immunosuppression?
  • Is the steroid stress-dose plan documented and accessible?
  • When is the next dose due, and who administers it?

These questions move vaccination from an annual scramble to a planned, calm element of routine care.

What is still uncertain

Optimal timing of certain vaccines around clinical trial participation, gene therapy infusion, and high-dose immunosuppression continues to be studied. National schedules evolve. New respiratory pathogens may produce new recommendations.

The reasonable framing is that vaccination in DMD is a high-value preventive measure with low and well-characterized risks, best planned with the care team in advance rather than reacted to during an illness.

For related reading, see respiratory care in DMD, corticosteroids in DMD, emergency preparedness for DMD families, and DMD standards of care.

Disclaimer: This post is informational and does not constitute medical advice. Decisions about diagnosis or treatment must be made with a qualified care team.